Clincosm LogoSign in Get a demo

Cancer

Showing NaN - NaN of 165
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Diabetes Trial in Houston (Fitbit, Continuous Glucose Monitor)

Suspended
  • Cancer
  • Diabetes
  • Fitbit
  • Continuous Glucose Monitor
  • Houston, Texas
    M D Anderson Cancer Center
Aug 25, 2022

Cancer Trial in Worldwide (Talazoparib)

Completed
Has Results
  • Cancer
  • Alhambra, California
  • +37 more
Jul 26, 2022

S1204, Viral Screening in Newly Diagnosed Cancer Patients

Active, not recruiting
  • Cancer
    • Fontana, California
    • +57 more
    Aug 22, 2022

    Long-Term Follow-Up of Recipient of Gene Transfer Research

    Recruiting
    • Retroviridae Infections
    • Cancer
    • Blood Tests
    • Questionnaires
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Aug 22, 2022

    Solid Tumor, Cancer, Carcinoma Trial in United States (Mogamulizumab + Nivolumab)

    Completed
    Has Results
    • Solid Tumor
    • +4 more
    • Mogamulizumab + Nivolumab
    • Gilbert, Arizona
    • +14 more
    Jul 27, 2022

    Cancer Trial in Worldwide (Atezolizumab)

    Recruiting
    • Cancer
    • Birmingham, Alabama
    • +178 more
    Aug 17, 2022

    Cancer, Aging, Communication Trial in Houston (Geriatric Assessment)

    Recruiting
    • Cancer
    • +2 more
    • Geriatric Assessment
    • Houston, Texas
      MD Anderson Cancer Center
    Aug 16, 2022

    Cancer, Solid Tumor, Solid Carcinoma Trial in Houston (AMXT1501, DFMO)

    Recruiting
    • Cancer
    • +18 more
    • Houston, Texas
      MD Anderson Cancer Center
    Aug 12, 2022

    Cancer Trial in United States (TTX-080, pembrolizumab, cetuximab)

    Recruiting
    • Cancer
    • Tucson, Arizona
    • +33 more
    Aug 3, 2022

    Sleep, Fatigue, Anxiety Trial in Houston (Cognitive Behavior Therapy, Bright Light Therapy, Methylphenidate)

    Not yet recruiting
    • Sleep
    • +4 more
    • Cognitive Behavior Therapy
    • +3 more
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 25, 2022

    Pediatric ALL, Cancer Trial in Houston (IPAD, Augmented Reality)

    Not yet recruiting
    • Pediatric ALL
    • Cancer
    • IPAD
    • Augmented Reality
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 18, 2022

    Advanced Cancer, Advanced Solid Tumor, Cancer Trial in Austin, Houston, Fairfax (BIO-106, Pembrolizumab)

    Recruiting
    • Advanced Cancer
    • +3 more
    • Austin, Texas
    • +2 more
    Jul 15, 2022

    Cancer, Solid Tumors Trial in United States (Vevorisertib, Fulvestrant, Paclitaxel)

    Terminated
    Has Results
    • Cancer
    • Solid Tumors
    • Las Vegas, Nevada
    • +5 more
    Jun 14, 2022

    Pulmonary Hemorrhage, Cancer Trial in Houston (tranexamic acid, Usual Care)

    Not yet recruiting
    • Pulmonary Hemorrhage
    • Cancer
    • tranexamic acid
    • Usual Care
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 10, 2022

    Cancer Trial in Worldwide (Dabrafenib, Trametinib)

    Completed
    • Cancer
    • Little Rock, Arkansas
    • +51 more
    Jun 8, 2022

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-219)

    Recruiting
    • Acute Myeloid Leukemia
    • +12 more
    • Los Angeles, California
    • +6 more
    Jun 1, 2022

    Cancer, Melanoma Trial in Worldwide (drug, biological, other)

    Recruiting
    • Cancer
    • Melanoma
    • Springdale, Arkansas
    • +70 more
    May 16, 2022

    KM3D Multicenter Cancer Consortium: Predicting Patient Response

    Recruiting
    • Cancer
    • +2 more
    • Known 3Dx Test
    • Durham, North Carolina
    • +1 more
    Apr 18, 2022

    Cancer Trial in Canada, United States (Vopratelimab, Ipilimumab)

    Active, not recruiting
    • Cancer
    • Beverly Hills, California
    • +20 more
    Apr 4, 2022

    Cancer Trial in United States (BBI608, Ipilimumab, Nivolumab)

    Completed
    • Cancer
    • Denver, Colorado
    • +7 more
    Apr 4, 2022

    Cancer Trial in Houston (LVGN7409)

    Recruiting
    • Cancer
    • LVGN7409
    • Houston, Texas
      MD Anderson Cancer Center
    Apr 4, 2022

    Solid Tumor, Adult, Cancer, Tumors Trial in United States (AdAPT-001)

    Recruiting
    • Solid Tumor, Adult
    • +2 more
    • AdAPT-001
    • San Marcos, California
    • +4 more
    Mar 24, 2022

    Thromboembolism in Cancer Patients: Experience atComprehensive

    Completed
    • Cancer
    • +3 more
    • Retrospective Chart Review
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Mar 22, 2022

    Cancer Trial in United States (JTX-8064, pimivalimab)

    Recruiting
    • Cancer
    • Birmingham, Alabama
    • +41 more
    Feb 25, 2022

    Brain Metastases, Cancer, Gliomas Trial in Houston (F18 Fluciclovine, Standard of Care)

    Not yet recruiting
    • Brain Metastases
    • +3 more
    • F18 Fluciclovine
    • Standard of Care
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 11, 2022